Gontran Verset

5.5k total citations
36 papers, 603 citations indexed

About

Gontran Verset is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gontran Verset has authored 36 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 16 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gontran Verset's work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Liver Disease and Transplantation (7 papers). Gontran Verset is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Liver Disease and Transplantation (7 papers). Gontran Verset collaborates with scholars based in Belgium, France and Italy. Gontran Verset's co-authors include Marianna Arvanitakis, Myriam Delhaye, Jacques Devière, Michel Cremer, Pieter Demetter, Marc Peeters, Raphaël Maréchal, Alain Hendlisz, Jean‐Luc Van Laethem and Marc Polus and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Gontran Verset

36 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gontran Verset Belgium	13	348	281	232	164	95	36	603
J. Furuse Japan	13	384 1.1×	281 1.0×	224 1.0×	231 1.4×	205 2.2×	40	708
Saya Igarashi Japan	12	206 0.6×	326 1.2×	262 1.1×	123 0.8×	234 2.5×	22	653
R. T. Ottow United States	8	361 1.0×	212 0.8×	251 1.1×	138 0.8×	52 0.5×	10	610
Cheng‐Hsiang Lo Taiwan	15	129 0.4×	142 0.5×	230 1.0×	173 1.1×	94 1.0×	40	501
Nicolas Moosmann Germany	12	449 1.3×	84 0.3×	107 0.5×	216 1.3×	34 0.4×	39	512
Markus Möhler Germany	15	428 1.2×	251 0.9×	64 0.3×	250 1.5×	35 0.4×	35	636
Richard M. Goldberg United States	12	433 1.2×	126 0.4×	103 0.4×	201 1.2×	114 1.2×	33	644
Michele Droz Dit Busset Italy	12	446 1.3×	589 2.1×	87 0.4×	264 1.6×	88 0.9×	24	785
Daitaro Yoshikawa Japan	9	398 1.1×	562 2.0×	72 0.3×	155 0.9×	43 0.5×	14	665
Joaquin Garcia United States	6	280 0.8×	231 0.8×	98 0.4×	126 0.8×	75 0.8×	9	450

Countries citing papers authored by Gontran Verset

Since Specialization

Citations

This map shows the geographic impact of Gontran Verset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gontran Verset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gontran Verset more than expected).

Fields of papers citing papers by Gontran Verset

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gontran Verset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gontran Verset. The network helps show where Gontran Verset may publish in the future.

Co-authorship network of co-authors of Gontran Verset

This figure shows the co-authorship network connecting the top 25 collaborators of Gontran Verset. A scholar is included among the top collaborators of Gontran Verset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gontran Verset. Gontran Verset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lucatelli, Pierleone, et al.. (2024). Long-Term Outcomes of Balloon TACE for HCC: An European Multicentre Single-Arm Retrospective Study. CardioVascular and Interventional Radiology. 47(8). 1074–1082. 5 indexed citations

Pauly, Nicolas, et al.. (2024). Impact of scatter correction on personalized dosimetry in selective internal radiotherapy using 166Ho-PLLA: a single-center study including Monte-Carlo simulation, phantom and patient imaging. EJNMMI Physics. 11(1). 33–33. 1 indexed citations

Moreno‐Reyes, Rodrigo, et al.. (2024). ¹⁶⁶ Ho‐RadioEmbolizaTiOn Using personalized prediCtive dosimetry in patients with Hepatocellular carcinoma: A prospective, single‐centre study ( RETOUCH ). Liver International. 45(4). e15923–e15923. 1 indexed citations

Verset, Gontran, Pieter De Bondt, Katrien De Keukeleire, et al.. (2024). Safety and efficacy of Holmium-166 selective internal radiotherapy of primary and secondary liver cancer confirmed by real-world data. Frontiers in Oncology. 14. 1404621–1404621. 2 indexed citations

Vouche, Michaël, Jason Bouziotis, Rodrigo Moreno‐Reyes, et al.. (2023). Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients. SHILAP Revista de lepidopterología. 7(1). 12–12. 4 indexed citations

Gomes, Filipe Veloso, et al.. (2023). Transarterial Chemoembolization with Anthracyclines-Loaded Polyethylene Glycol Drug Eluting Microspheres for the Treatment of Hepatocellular Carcinoma: A Pooled Multicentric Analysis of Survival in 580 Patients. CardioVascular and Interventional Radiology. 46(4). 436–446. 7 indexed citations

Verset, Gontran, et al.. (2022). Duodenal Hemorrhage Due to an Invasive Hepatocellular Carcinoma Controlled by Transarterial Embolization. Cureus. 14(11). e32046–e32046. 1 indexed citations

Vonghia, Luisa, et al.. (2022). Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma. World Journal of Hepatology. 14(8). 1608–1620. 2 indexed citations

Sakr, Rita A., et al.. (2021). Unusual metastasis in BRCA mutated pancreatic cancer while on maintenance Olaparib: Two case reports and review of the literature. European Journal of Cancer. 157. 63–67. 2 indexed citations

10.

Kelley, Robin Kate, Thomas Yau, Ann‐Lii Cheng, et al.. (2021). VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized phase III COSMIC-312 trial. Annals of Oncology. 33(1). 114–116. 48 indexed citations

11.

Golfieri, Rita, Mario Bezzi, Gontran Verset, et al.. (2021). Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching. Liver Cancer. 10(5). 522–534. 21 indexed citations

12.

Golfieri, Rita, Mario Bezzi, Gontran Verset, et al.. (2021). Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis. CardioVascular and Interventional Radiology. 44(7). 1048–1059. 19 indexed citations

13.

Verset, Gontran, et al.. (2021). Complete response of a hepatocellular carcinoma with complex macrovascular invasion after combined treatment with chemoembolization and immunotherapy: a case report. Acta Gastro Enterologica Belgica. 84(2). 371–374. 2 indexed citations

14.

Liu, Ken, Gontran Verset, Eric Trépo, & Devanshi Seth. (2020). Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction. Hepatoma Research. 2020. 7 indexed citations

15.

Craciun, Ligia, Pieter Demetter, Valério Lucidi, et al.. (2020). Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy. BMC Cancer. 20(1). 135–135. 41 indexed citations

16.

Baère, Thierry de, Boris Guiu, Maxime Ronot, et al.. (2020). Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry. Cancers. 12(11). 3405–3405. 14 indexed citations

17.

Jansen, Yanina, Gontran Verset, Pieter‐Jan van Dam, et al.. (2019). Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases. ESMO Open. 4(2). e000464–e000464. 20 indexed citations

18.

Drouillard, Antoine, Francesco Puleo, Jean‐Baptiste Bachet, et al.. (2016). DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. British Journal of Cancer. 115(10). 1245–1252. 16 indexed citations

19.

Lemmers, Arnaud, Sylvie Evrard, Pieter Demetter, et al.. (2014). Gastrointestinal polypoid lesions: a poorly known endoscopic feature of portal hypertension. United European Gastroenterology Journal. 2(3). 189–196. 17 indexed citations

20.

Verset, Gontran, Chris Verslype, Hendrik Reynaert, et al.. (2007). Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study. British Journal of Cancer. 97(5). 582–588. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact